| Jun 3 |
FDA considers updating COVID boosters, Novavax stock reacts
|
| Jun 3 |
Genmab and BioNTech report data from Phase II GCT1046-04 trial for mNSCLC
|
| Jun 1 |
BioNTech/ Genmab lung cancer therapy improves survival with Keytruda
|
| Jun 1 |
Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)
|
| May 31 |
NHS launches personalised mRNA cancer vaccines trial
|
| May 30 |
BioNTech and CEPI expand deal to boost Africa’s vaccine capabilities
|
| May 29 |
BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem
|
| May 28 |
BioNTech gains antibody drug conjugate platform license from Chinese biotech
|
| May 28 |
Jim Cramer: Celestica Makes A 'Comeback,' Sell This Movie Theater Stock,
|
| May 27 |
MediLink Therapeutics announces a multi-target TMALIN® ADC technology platform license agreement with BioNTech, expanding their global strategic partnership
|
